Is NuScale the Best Nuclear Stock to Buy?
NuScale Power (NYSE:SMR) is a nuclear power startup that has…
Sell
34
RNA Quote, Financials, Valuation and Earnings
Last price:
$29.93
Seasonality move
:
3.75%
Day range:
$29.23 - $30.30
52-week range:
$21.51 - $56.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
408.35x
P/B ratio:
2.71x
Volume:
1.4M
Avg. volume:
1.4M
1-year change:
-24.68%
Market cap:
$3.6B
Revenue:
$10.9M
EPS (TTM):
-$3.00
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6.8M | $9.3M | $9.2M | $9.6M | $10.9M | |
| Revenue Growth (YoY) | 192.67% | 37.41% | -1.09% | 3.64% | 13.99% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $37.6M | $101.2M | $150.4M | $191M | $303.6M | |
| Selling, General & Admin | $13.5M | $26.2M | $37.7M | $54.2M | $86.2M | |
| Other Inc / (Exp) | -$75K | -$62K | -$57K | -$594K | -$248K | |
| Operating Expenses | $51.1M | $127.4M | $188.1M | $245.2M | $389.8M | |
| Operating Income | -$44.3M | -$118.1M | -$178.9M | -$235.6M | -$378.9M | |
| Net Interest Expenses | $3K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$44.4M | -$118M | -$174M | -$212.2M | -$322.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$44.4M | -$118M | -$174M | -$212.2M | -$322.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$44.4M | -$118M | -$174M | -$212.2M | -$322.3M | |
| Basic EPS (Cont. Ops) | -$2.05 | -$2.85 | -$3.34 | -$2.91 | -$2.89 | |
| Diluted EPS (Cont. Ops) | -$2.05 | -$2.85 | -$3.34 | -$2.91 | -$2.89 | |
| Weighted Average Basic Share | $21.7M | $41.4M | $52.2M | $73M | $111.6M | |
| Weighted Average Diluted Share | $21.7M | $41.4M | $52.2M | $73M | $111.6M | |
| EBITDA | -$43.8M | -$117.4M | -$177.5M | -$233.5M | -$376.2M | |
| EBIT | -$44.1M | -$118.1M | -$178.9M | -$235.6M | -$378.9M | |
| Revenue (Reported) | $6.8M | $9.3M | $9.2M | $9.6M | $10.9M | |
| Operating Income (Reported) | -$44.3M | -$118.1M | -$178.9M | -$235.6M | -$378.9M | |
| Operating Income (Adjusted) | -$44.1M | -$118.1M | -$178.9M | -$235.6M | -$378.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.7M | $1.8M | $2.2M | $3.5M | $1.6M | |
| Revenue Growth (YoY) | 99.12% | -33.62% | 24.4% | 58.67% | -55.6% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $20.7M | $27.7M | $47.8M | $66.8M | $99.5M | |
| Selling, General & Admin | $5.9M | $8.6M | $12.1M | $13.9M | $33.6M | |
| Other Inc / (Exp) | -$3K | -$25K | -$314K | -$101K | -$435K | |
| Operating Expenses | $26.6M | $36.3M | $59.8M | $80.7M | $133.1M | |
| Operating Income | -$23.9M | -$34.5M | -$57.6M | -$77.2M | -$131.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$23.8M | -$34.2M | -$52.4M | -$68.9M | -$115.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$23.8M | -$34.2M | -$52.4M | -$68.9M | -$115.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$23.8M | -$34.2M | -$52.4M | -$68.9M | -$115.8M | |
| Basic EPS (Cont. Ops) | -$0.64 | -$0.71 | -$0.74 | -$0.79 | -$0.90 | |
| Diluted EPS (Cont. Ops) | -$0.64 | -$0.71 | -$0.74 | -$0.79 | -$0.90 | |
| Weighted Average Basic Share | $37.5M | $48.2M | $70.4M | $87.2M | $129.2M | |
| Weighted Average Diluted Share | $37.5M | $48.2M | $70.4M | $87.2M | $129.2M | |
| EBITDA | -$23.7M | -$34.1M | -$57.2M | -$76.5M | -$130.7M | |
| EBIT | -$23.9M | -$34.5M | -$57.6M | -$77.2M | -$131.5M | |
| Revenue (Reported) | $2.7M | $1.8M | $2.2M | $3.5M | $1.6M | |
| Operating Income (Reported) | -$23.9M | -$34.5M | -$57.6M | -$77.2M | -$131.5M | |
| Operating Income (Adjusted) | -$23.9M | -$34.5M | -$57.6M | -$77.2M | -$131.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.1M | $8.4M | $9.7M | $10.9M | $8.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $52.7M | $108.2M | $170.5M | $210M | $336.3M | |
| Selling, General & Admin | $17.4M | $28.9M | $41.2M | $56M | $105.9M | |
| Other Inc / (Exp) | -$78K | -$84K | -$346K | -$381K | -$582K | |
| Operating Expenses | $70.1M | $137.1M | $211.7M | $266.1M | $442.2M | |
| Operating Income | -$62M | -$128.7M | -$202M | -$255.2M | -$433.3M | |
| Net Interest Expenses | $52K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$62.1M | -$128.4M | -$192.2M | -$228.7M | -$369.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$62.1M | -$128.4M | -$192.2M | -$228.7M | -$369.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$62.1M | -$128.4M | -$192.2M | -$228.7M | -$369.2M | |
| Basic EPS (Cont. Ops) | -$2.61 | -$3.73 | -$3.36 | -$2.96 | -$3.00 | |
| Diluted EPS (Cont. Ops) | -$2.61 | -$3.73 | -$3.36 | -$2.96 | -$3.00 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$61.6M | -$127.8M | -$200.6M | -$252.8M | -$430.3M | |
| EBIT | -$62M | -$128.7M | -$202M | -$255.2M | -$433.3M | |
| Revenue (Reported) | $8.1M | $8.4M | $9.7M | $10.9M | $8.9M | |
| Operating Income (Reported) | -$62M | -$128.7M | -$202M | -$255.2M | -$433.3M | |
| Operating Income (Adjusted) | -$62M | -$128.7M | -$202M | -$255.2M | -$433.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.7M | $1.8M | $2.2M | $3.5M | $1.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $20.7M | $27.7M | $47.8M | $66.8M | $99.5M | |
| Selling, General & Admin | $5.9M | $8.6M | $12.1M | $13.9M | $33.6M | |
| Other Inc / (Exp) | -$3K | -$25K | -$314K | -$101K | -$435K | |
| Operating Expenses | $26.6M | $36.3M | $59.8M | $80.7M | $133.1M | |
| Operating Income | -$23.9M | -$34.5M | -$57.6M | -$77.2M | -$131.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$23.8M | -$34.2M | -$52.4M | -$68.9M | -$115.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$23.8M | -$34.2M | -$52.4M | -$68.9M | -$115.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$23.8M | -$34.2M | -$52.4M | -$68.9M | -$115.8M | |
| Basic EPS (Cont. Ops) | -$0.64 | -$0.71 | -$0.74 | -$0.79 | -$0.90 | |
| Diluted EPS (Cont. Ops) | -$0.64 | -$0.71 | -$0.74 | -$0.79 | -$0.90 | |
| Weighted Average Basic Share | $37.5M | $48.2M | $70.4M | $87.2M | $129.2M | |
| Weighted Average Diluted Share | $37.5M | $48.2M | $70.4M | $87.2M | $129.2M | |
| EBITDA | -$23.7M | -$34.1M | -$57.2M | -$76.5M | -$130.7M | |
| EBIT | -$23.9M | -$34.5M | -$57.6M | -$77.2M | -$131.5M | |
| Revenue (Reported) | $2.7M | $1.8M | $2.2M | $3.5M | $1.6M | |
| Operating Income (Reported) | -$23.9M | -$34.5M | -$57.6M | -$77.2M | -$131.5M | |
| Operating Income (Adjusted) | -$23.9M | -$34.5M | -$57.6M | -$77.2M | -$131.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $321.5M | $320.4M | $340.4M | $185.1M | $219.9M | |
| Short Term Investments | $6.7M | $85.1M | $270.3M | $410.3M | $1.3B | |
| Accounts Receivable, Net | -- | -- | $2.4M | $1.1M | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | $8.3M | $7.3M | $12.6M | |
| Other Current Assets | $3.5M | $5.6M | -- | -- | -- | |
| Total Current Assets | $331.7M | $411.1M | $622.9M | $611.3M | $1.5B | |
| Property Plant And Equipment | $1.9M | $15.6M | $15M | $16.7M | $18.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $298K | $850K | $849K | $596K | $3.3M | |
| Total Assets | $333.9M | $427.6M | $638.8M | $628.6M | $1.6B | |
| Accounts Payable | -- | $2.8M | $4.6M | $8.8M | $8.5M | |
| Accrued Expenses | -- | $11.3M | $27.9M | $25.5M | $61.1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $1.8M | $3.1M | $3.6M | $3.8M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $14.6M | $29.7M | $51.9M | $80.7M | $98M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $27.7M | $46.2M | $60.7M | $127.8M | $138.9M | |
| Common Stock | $4K | $5K | $7K | $8K | $12K | |
| Other Common Equity Adj | -$5K | -$187K | -$2.7M | $125K | $2.9M | |
| Common Equity | $306.2M | $381.4M | $578.1M | $500.8M | $1.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $306.2M | $381.4M | $578.1M | $500.8M | $1.4B | |
| Total Liabilities and Equity | $333.9M | $427.6M | $638.8M | $628.6M | $1.6B | |
| Cash and Short Terms | $328.1M | $405.5M | $610.7M | $595.4M | $1.5B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $301.3M | $139.3M | $118.7M | $471.4M | $254.2M | |
| Short Term Investments | $6.6M | $257.8M | $467.6M | $444.5M | $1.1B | |
| Accounts Receivable, Net | -- | -- | -- | $1.6M | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | $9.6M | $18.5M | |
| Other Current Assets | $4M | $7.7M | $10.8M | -- | -- | |
| Total Current Assets | $312M | $404.8M | $597.1M | $934.5M | $1.4B | |
| Property Plant And Equipment | $2.2M | $15.3M | $16.1M | $16.3M | $20.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $615K | $1M | $725K | $720K | $3.5M | |
| Total Assets | $314.8M | $421.1M | $614M | $951.5M | $1.5B | |
| Accounts Payable | -- | -- | $3.9M | $2.3M | $6.6M | |
| Accrued Expenses | -- | -- | $30M | $35M | $47.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $2.5M | $3.1M | $3.7M | $3.9M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $17.5M | $30.9M | $48.1M | $75M | $84.9M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $28.6M | $45.4M | $55.1M | $120.6M | $130.4M | |
| Common Stock | $4K | $5K | $7K | $10K | $12K | |
| Other Common Equity Adj | -$3K | -$2M | -$1.5M | -$464K | $2.8M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $286.1M | $375.7M | $558.9M | $830.9M | $1.3B | |
| Total Liabilities and Equity | $314.8M | $421.1M | $614M | $951.5M | $1.5B | |
| Cash and Short Terms | $307.9M | $397.1M | $586.3M | $915.9M | $1.4B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$44.4M | -$118M | -$174M | -$212.2M | -$322.3M | |
| Depreciation & Amoritzation | $373K | $639K | $1.4M | $2.1M | $2.8M | |
| Stock-Based Compensation | $4.3M | $17.1M | $27.1M | $38.2M | $51.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$37.1M | -$94.8M | -$136.3M | -$119.1M | -$300.9M | |
| Capital Expenditures | $1.1M | $3.7M | $2.8M | $4.2M | $7.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$7.8M | -$82.5M | -$190M | -$130.1M | -$854.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$4.7M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $272M | $176.3M | $346.2M | $93.9M | $1.2B | |
| Beginning Cash (CF) | $94.6M | $321.7M | $320.7M | $340.6M | $185.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $227.1M | -$1M | $19.9M | -$155.3M | $37.3M | |
| Ending Cash (CF) | $321.7M | $320.7M | $340.6M | $185.4M | $222.7M | |
| Levered Free Cash Flow | -$38.2M | -$98.6M | -$139.1M | -$123.3M | -$307.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$23.8M | -$34.2M | -$52.4M | -$68.9M | -$115.8M | |
| Depreciation & Amoritzation | $108K | $314K | $391K | $641K | $785K | |
| Stock-Based Compensation | $3.7M | $6.2M | $9.1M | $10.3M | $17.7M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$19.7M | -$29.6M | -$49M | -$70.4M | -$124.8M | |
| Capital Expenditures | $525K | $758K | $1.8M | $915K | $3.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$525K | -$175.5M | -$195.7M | -$32.7M | $157.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $17K | $24.1M | $23M | $389.4M | $1.9M | |
| Beginning Cash (CF) | $321.7M | $320.7M | $340.6M | $185.4M | $222.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | $39K | |
| Additions / Reductions | -$20.2M | -$180.9M | -$221.7M | $286.3M | $34.3M | |
| Ending Cash (CF) | $301.5M | $139.8M | $119M | $471.7M | $257M | |
| Levered Free Cash Flow | -$20.2M | -$30.3M | -$50.8M | -$71.3M | -$128.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$62.1M | -$128.4M | -$192.2M | -$228.7M | -$369.2M | |
| Depreciation & Amoritzation | $398K | $845K | $1.5M | $2.4M | $2.9M | |
| Stock-Based Compensation | $7.6M | $19.6M | $30M | $39.4M | $58.8M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$49.7M | -$104.7M | -$155.7M | -$140.5M | -$355.3M | |
| Capital Expenditures | $1.6M | $4M | $3.9M | $3.3M | $9.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$8.3M | -$257.5M | -$210.2M | $32.9M | -$664.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $270.7M | $200.4M | $345M | $460.3M | $804.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $212.8M | -$161.8M | -$20.8M | $352.7M | -$214.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$51.3M | -$108.7M | -$159.5M | -$143.8M | -$365.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$23.8M | -$34.2M | -$52.4M | -$68.9M | -$115.8M | |
| Depreciation & Amoritzation | $108K | $314K | $391K | $641K | $785K | |
| Stock-Based Compensation | $3.7M | $6.2M | $9.1M | $10.3M | $17.7M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$19.7M | -$29.6M | -$49M | -$70.4M | -$124.8M | |
| Capital Expenditures | $525K | $758K | $1.8M | $915K | $3.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$525K | -$175.5M | -$195.7M | -$32.7M | $157.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $17K | $24.1M | $23M | $389.4M | $1.9M | |
| Beginning Cash (CF) | $321.7M | $320.7M | $340.6M | $185.4M | $222.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | $39K | |
| Additions / Reductions | -$20.2M | -$180.9M | -$221.7M | $286.3M | $34.3M | |
| Ending Cash (CF) | $301.5M | $139.8M | $119M | $471.7M | $257M | |
| Levered Free Cash Flow | -$20.2M | -$30.3M | -$50.8M | -$71.3M | -$128.6M | |
Get RNA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RNA
Sector
P/E ratio
--
24.27x
PEG ratio
-7.37x
0.00x
P/B ratio
2.71x
1.75x
Price / LTM sales
408.35x
1.61x
Growth Metrics
RNA
Sector
Revenue growth
-55.6%
4.37%
Earnings growth
--
7.49%
Revenue (5-year growth)
36.27%
8.07%
Earnings forecast
-$0.88
-$0.21
Profitability
RNA
Sector
Profitability FY 2025
--
$49.1M
Return on invested capital
-29.26%
-15.44%
Return on assets
-26.51%
-12.56%
Return on equity
-29.26%
-17.68%
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
7
Balance Sheet
RNA
Sector
Total cash
$1.4B
$36.7M
Short term investments
$1.3B
$31M
Total assets
$1.6B
$113.1M
Long term debt
--
$7.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Kestra Medical Stock Be in 1 Year?
Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…
Why Did Howard Marks Buy Grab Stock?
When a legendary value investor who cut his teeth in…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 42x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 50x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
58
AMBA alert for Jun 25
Ambarella [AMBA] is up 4.36% over the past day.
Buy
65
EXOD alert for Jun 25
Exodus Movement [EXOD] is down 9.63% over the past day.
Buy
78
SMR alert for Jun 25
NuScale Power [SMR] is down 10.59% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
